InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (41 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
41
T+90 hit rate
26%
T+90 mean return
+3.3%
Across 23 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by RAAB MICHAEL, Chief Executive Officer. Insider active across 2 companies, notably Amicus Therapeutics, INC.. In total, 73 reports have been recorded. Split: 1 buy · 41 sells. Total volume traded: €2.7m. Activity tracked since 18 May 2021. The latest transaction was filed on 21 May 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations73 total
14,933 shares@ US$6.26750.0057% mcap2.5% of flowCommon StockSEC:0001321402-26-000012:0
7,861 shares@ US$6.26750.0030% mcap1.3% of flowCommon StockSEC:0001321402-26-000012:1
17,926 shares@ US$6.26750.0068% mcap3.1% of flowCommon StockSEC:0001321402-26-000012:2
14,028 shares@ US$6.26750.0053% mcap2.4% of flowCommon StockSEC:0001321402-26-000012:3
20,833 shares@ US$0.990.0012% mcap0.6% of flowCommon StockSEC:0001321402-26-000009:0
41,666 shares@ US$6.27880.016% mcap7.1% of flowCommon StockSEC:0001321402-26-000009:1
46,887 shares@ US$5.53697.1% of flowCommon StockSEC:0001610717-25-000396:0
46,817 shares@ US$4.08145.3% of flowCommon StockSEC:0001628280-25-027429:0
20,833 shares@ US$0.990.6% of flowCommon StockSEC:0001628280-25-022355:0
20,833 shares@ US$0.990.6% of flowCommon StockSEC:0001628280-25-017125:0
41,666 shares@ US$4.58775.5% of flowCommon StockSEC:0001628280-25-017125:1
20,834 shares@ US$0.990.6% of flowCommon StockSEC:0001628280-25-011441:0
570,217 shares0Common StockSEC:0001628280-25-008796:0
22,964 shares@ US$5.62293.9% of flowCommon StockSEC:0001628280-25-007230:0
20,833 shares@ US$0.990.6% of flowCommon StockSEC:0001628280-25-003378:0
20,833 shares@ US$0.990.6% of flowCommon StockSEC:0001628280-25-001178:0
25,000 shares@ US$0.990.7% of flowCommon StockSEC:0001628280-24-051104:0
25,000 shares@ US$5.37934.1% of flowCommon StockSEC:0001628280-24-049423:0
31,980 shares@ US$4.79454.6% of flowCommon StockSEC:0001628280-24-049051:0
2,743 shares@ US$4.900.4% of flowCommon StockSEC:0001628280-24-047271:0
25,000 shares@ US$0.990.7% of flowCommon StockSEC:0001628280-24-044440:0
7,500 shares@ US$6.011.3% of flowCommon StockSEC:0001628280-24-042853:0
3,000 shares@ US$6.070.5% of flowCommon StockSEC:0001628280-24-041474:0
35,000 shares@ US$0.991.0% of flowCommon StockSEC:0001628280-24-040355:0
7,500 shares@ US$6.2181.3% of flowCommon StockSEC:0001628280-24-038719:0
25 of 73 declarations
About RAAB MICHAEL
Michael Raab is an executive at Amicus Therapeutics, Inc.
